More on XENE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xenon Pharmaceuticals (NQ:XENE)
Delayed: 41.94 -0.11 (0.26%)
Prev. Close $42.05  
Open$41.81 
52 Wk High$9.75 
52 Wk Low$5.65 
Day High$42.24 
Day Low$41.05 
P/E N/A  
EPS$0.00 
Volume1,084,872 

Friends, Peers and Foes (?): CMPS, INSM, ACAD, BCRX, ASND (more...)

Feb 27, 2026 04:04 PM Form 8-K Xenon Pharmaceuticals For: Feb 27
Feb 27, 2026 04:03 PM Form 424B5 Xenon Pharmaceuticals
Feb 27, 2026 08:29 AM Xenon Pharmaceuticals (XENE) PT Raised to $59 at RBC Capital
Feb 27, 2026 06:59 AM Xenon Pharmaceuticals (XENE) PT Raised to $49 at Wells Fargo
Feb 26, 2026 05:16 PM Xenon Pharmaceuticals (XENE) Misses Q4 EPS by 12c
Feb 26, 2026 04:20 PM Form 10-K Xenon Pharmaceuticals For: Dec 31
Feb 26, 2026 04:05 PM Form 8-K Xenon Pharmaceuticals For: Feb 26
Feb 26, 2026 04:01 PM Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
Feb 23, 2026 04:05 PM Wolfe Research Starts Xenon Pharmaceuticals (XENE) at Outperform, Top Pick
Feb 10, 2026 11:23 AM Form SCHEDULE 13G Xenon Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
View All Articles

Entities mentioned with XENE

View All Entities